저자: 미상 · 외국인
요약 보기
결론: 캐시 우드 ARK 포트폴리오 상위 종목을 분석하며 일부 성장주 투자 검토를 권하나, 대부분 고평가·적자 리스크를 강조함. [ARK 펀드 성과] 최근 1년 ARKK 수익률 54%, 누적 190% 수준으로 S&P500(45%) 대비 우위라고 언급. 캐시 우드의 테슬라 목표가(2024년 7,000달러) 등 강세 목표가를 소개. [테슬라] 사이버트럭 대규모 선주문(50만 대 이상), 상하이 기가팩토리 성장, 모델Y 램프업, 세미·비전 등 성장 동력 제시. 주가는 1년간 250% 상승해 이미 고평가 부담 존재, 장기 투자 관점에서는 가치 있을 수 있다는 입장. [스퀘어(Block)] POS 단말기 기반 수수료 모델, 캐시앱(고객 700만 명), 스퀘어 캐피털 등 생태계 확장. 트레일링 PER 122, PSR 7로 프리미엄 가격. [인비테이 등 유전체 검사 기업] 가족·진단·보인자·예방 검사 서비스(검사당 약 250달러). 2020년 매출 38%, 2021년 53% 성장 전망. 현재 연간 약 3억 달러 적자, 현금 3.91억 달러, PSR 6으로 고평가. [크리스퍼 테라퓨틱스] 유전자 편집 기술 기반, 장기 임상 중심. 2019년 간신히 흑자 전환 수준, 향후 연구 결과에 따라 좌우. [투 유(2U)] 온라인 학위 사업으로 팬데믹 수혜 성장, 그러나 연간 약 2억 달러 적자로 투기적 성장주로 평가. [알루미나(Illumina 계열 언급)] DNA 시퀀싱 기업, PER 58, PSR 15로 고평가. 2020년 매출 0.9%, 2021년 15% 성장 전망. [프로토랩스] 3D 프린팅 제조 서비스, 의료용품 수요 급증으로 주가 64→126달러. PER 58, PSR 7이나 2020년 매출 -6%, 2021년 +10%로 밸류에이션 매력 낮다는 평가. [질로우] 주택 매입 자회사(Zillow Offers) 리스크 존재, 2020년 매출 36%·2021년 67% 성장 전망, 연간 2억 달러 적자, 주택 가격 급락 시 위험. [로쿠] 스트리밍 기기 기업, 아마존 파이어스틱 등과 경쟁. PSR 10, 2020·2021년 약 30% 성장, 연간 약 5,900만 달러 적자, 현금 5.15억 달러. 경쟁 심화로 회피 의견. [스트라타시스] 3D 프린터 제조사, 2020년 매출 -10%, 2021년 +7.5%. PSR 1.6으로 저평가, 거의 손익분기점. 5년간 주가 50% 하락, 과거 ARKK 2위 보유 종목. [결론 정리] 여러 성장주가 고평가 또는 적자 상태라 선별 투자 필요. 장기 관점에서 일부 종목 매력 있으나 리스크 큼.
다듬은 글
a $4,000 price target to the shares at one point yes Kathy would the investment advisor of arc invest is most famous for her bullish price targets on Tesla stock as a price target for Tesla stock is $7,000 by 2024 while this may seem like an outrageously high price target her most popular fund the arc invests innovation ETF has produced quite impressive returns over the past few years in the past year the arc invest innovation ETF or AR KK has generated a return of 54 percent the fund has had a total return of 190 percent which is pretty incredible given the S&P 500's return a 45 percent over the same time in this video we're going to take a look at the top 10 holdings in the AR KK portfolio and analyze whether or not you should invest into any of these stocks if you're new to the channel please consider subscribing now let's get right into it Tesla's thought has been and will be the largest holding of the arc invest ETF which doesn't come as a surprise given Cathy's bullish price targets Tesla is a growth stock that truly has a bright future ahead of it let's take a look at a few growth opportunities ahead of Tesla despite the unconventional design the cyber truck has unprecedented demand with at least 500,000 pre-orders along with this the Shanghai Giga Factory has been growing at an incredibly rapid rate which will allow Tesla to eventually meet a demand for its vehicles the model y is starting to ramp up and the Tesla semi and Basara will follow up in 2021 the growth story is certainly appealing for Tesla but it definitely comes at a price the stock is already up 250 percent in the past year but as long as you're in for the long term the price may prove to be worth it square is another company that's most famous for its POS which stands for a point for sale squares POS is used with a device named the square stand which allows the customer to easily pay for products and add tips if they would like to this device is used in plenty of restaurants and retail stores and retails for $800 the reason why this business model is so strong is that after this device is purchased Square takes a percentage of the money that is used to buy products the company also owns Cash Shop which is a product very similar to PayPal as it allows you to transfer money to other people as of 2018 the product has 7 million active users square also has plenty of other products that are attached to its ecosystem including the square reader which reads credit and debit cards square appointments which allows users to book appointments and Square Capital which finances small businesses with loans all of this trades for a premium right now as the stock has a trailing pde ratio of 122 and a priceless sales ratio of 7 invitee is another growth company that is involved in the sector of genetics the company offers services including family testing diagnostic testing carrier screening and proactive tests these terms may seem confusing at first but it's actually quite simple so let's go over each segment one by one when one of your family members has tested positive for a genetic disease family testing gives you insight on what your risks are for developing the same disease diagnostic testing helps you confirm a suspected disease and provide a medical diagnosis for your symptoms this genetic testing also makes you eligible for clinical trials which is especially helpful for rare diseases carrier screening helps parents find out whether they are a carrier of a genetic disorder that they may pass on to their child proactive testing is a general testing to assess your health risks on a wide variety of diseases this healthy stay away from diseases that you are at a higher risk of contracting even if you don't have any symptoms each of these tests cost around $250 with some a little cheaper and some a little more expensive invitees genetic tests are becoming more widely used as time passes by their revenue is continuing to accelerate in the coming years in 2020 invitees revenue is expected to grow 38% and in 2021 the company's revenue is expected to grow 53% however the company is not profitable yet and also trades at a premium invitee is currently losing three hundred million dollars per year and only has 391 million dollars of cash the stock has a price to sales ratio of 6 which is relatively high if you're interested in the growth of genetic testing this may be a stock you want to look into imagine that a baby is born with a genetic disease what if you just edited the baby's DNA so that the baby would turn back to normal while this room to debate on whether that is ethical or not that is a question that is being tackled at CRISPR therapeutics CRISPR therapeutics is a company focused on editing the genes of animals plants and microbes CRISPR has proven to be able to engineer larger Tomatoes longer-lasting mushrooms and leaner pigs for healthier bacon eventually the goal of the company is to help babies that have genetic diseases but I will certainly take them both a lot of money and plenty of clinical trials CRISPR was barely able to make a profit in 2019 and the future of the business will depend on the results of its ongoing research gene editing has a lot of potential to take over our future and CRISPR is a way to get into that future to you is a company that offers online degrees for plenty of top-tier colleges which is a business that has grown at a fast rate during the current pandemic the list of schools on to use list is continuing to expand as time passes by making it a growth stock however the company has yet to turn a profit and is losing a little above 200 million dollars per year online degrees could become our future because the lowers tuition and is easy to access nonetheless to you is more of a speculative growth stock which seems to be a pattern we are seeing in the arc invest innovation ETF alumina is a stock that has gotten a lot of popularity on YouTube when youtuber chicken genius Singapore announced that us buying the stock essentially what alumina does is read DNA sequences in order to help us better understand health and disease the stock currently trades at a pde ratio of 58 and a price to sales ratio of 15 which is relatively high considering that the company's revenue is expected to grow 0.9 percent in 2020 and 15 percent in 2021 with labs in the name this may seem like another biology related stock however proto labs is actually a 3d printing manufacturer of varying types of tools proto labs will allow you to bring a prototype to manufacturing the first step is to send a file of your 3d printing design to proto labs proto labs will send you the pricing to manufacture that design and provide an analysis on whether your design is ready for manufacturing during the pandemic total labs has seen massive growth in the manufacturing of medical supplies and is deemed as an essential business the stock went from just $64 to 126 dollars because of the increased production of medical devices because of this the stock trades at a pde ratio of 58 and a price to sales of seven the company's revenue is expected to decline 6% in 2020 and increased 10% in 2021 which doesn't make the valuation very appealing in my opinion similar to Tesla Zillow stock has an extremely high short interest however under all this Jordan Kaos Zillow may actually have potential in the future the company is expected to have its revenue in 2020 growth 36% and in 2021 grows 67% nevertheless this revenue growth is coming at a cost Zillow is attempting to expand its current business by becoming more of a real estate company this is all done through a business called Zillow offers a person who wants to sell their house can call Zillow and Zillow will use an algorithm to determine the price of the house along with the algorithm Zillow will also send an agent to inspect the cost of repairs and Zillow will buy the house expecting returns in the future the company is currently losing 200 million dollars per year and is in a risky position for the case of a housing crash Roku is a company that sells a streaming device allowing you to watch the streaming services you would like to watch in an organized manner however the company has received competition from other companies like Amazon the Amazon firestick is a well known competitor to the Roku streaming device remote Roku stock trades at a premium with the prices sales ratio of 10 and has his revenue expected to grow slightly about 30% in 2020 and 2021 the company is currently losing 59 million dollars per year past five hundred fifteen million dollars of cash to back that up overall Roku is a fast-growing stock but is competing in a rather competitive environment which personally makes me avoid the stock stratasys is a company that manufactures 3d printers for the use of rapid prototyping the company is working on making its 3d printers faster higher quality and more energy efficient however stratasys has been facing competition from HP proto labs and 3d systems keep in mind that photo labs is actually a competitor to Stratasys which is interesting because it seems like Cathy wood isn't afraid of investing in companies that are competitors to one another Stratasys is revenue is expected to decline 10 percent in 2020 but increased 7.5 percent in 2021 because of this decline the stock is trading at a low valuation compared to its competitors as its price to sales ratio is only 1.6 the company is about to break even with around eight hundred seventeen thousand dollars lost in the past year from net income Stratasys could become a turnaround stock as it has lost 50% of its price in the last five years and actually used to be the second largest holding in the AR KK portfolio let me know what you think about Cathy woods portfolio in the comments section below if you enjoyed this video please hit the like button and subscribe so that I know you want to see more videos like this I appreciate your support
Comments 0